Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC

NCT03780010 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: TRC105

Sponsor

Tracon Pharmaceuticals Inc.

Collaborators

[object Object]